《睡眠專業人士雜誌》
星期五, 七月 24, 2026
Siemens Healthineers has entered into a definitive agreement to acquire Epocal Inc., a subsidiary of Alere Inc. Epocal Inc. develops and provides point-of-care blood diagnostic systems for healthcare enterprises, including the epoc® Blood Analysis System, a handheld, wireless testing solution. Financial details of the transaction are not being disclosed. The […]
RespiratoryBooks.com (Health Educator Publications, Inc.) has announced that you can now pre-order all of Oakes’ titles in one bundle and save almost $60. Bundle includes: 2018 Neonatal/Pediatric Respiratory Care Pocket Guide 2018 Neonatal/Pediatric Respiratory Simulations Student License/Workbook* 2017 Adult Respiratory Simulations License/Workbook* 2017 Respiratory Care Pocket Guide 2017 Hemodynamic […]
MedTech Breakthrough, an independent organization that recognizes the top companies, technologies and products in the global health and medical technology market, today announced that the VOCSN unified respiratory system from Ventec Life Systems, an innovator in integrated respiratory care solutions, has been selected as winner of the “Best New Therapeutic […]
Dymedix® Diagnostics, Inc., the leading global manufacturer of polyvinylidene (PVDF) sleep diagnostics sensors, today announced the first phase of the company’s restructuring is now complete, and the new team members will be attending the SLEEP2017 meeting in Boston, 六月 4 -8th, 2017. This restructuring process commenced last year and has […]
研究顯示，對於晚期疾病患者，結合居家非侵入性呼吸照護與居家氧療可延緩住院再入院時間。近期發表的肺部研究進展指出，將非侵入性呼吸照護（NIV）與居家氧療（HOT）結合使用，可顯著延長[…]患者的再入院或死亡時間。
專門生產聚偏二氟乙烯（PVDF）基睡眠診斷感測器的 Dymedix® Diagnostics, Inc. 宣布，已完成建立全球分銷網絡的第一階段。截至目前，該網絡由專營多導睡眠圖配件的美國國內及全球其他地區（ROW）授權經銷商共同組成。該公司計劃擴展 […]
VORTRAN Medical 已為其名為 GO2VENT（氣動式呼吸機）的全新改良型自動復甦器，取得美國食品藥物管理局（FDA）510K 認證及 CE 認證。這款產品線的最新成員，為患者在接受 MRI 或 CT 掃描期間提供了通氣選項。GO2VENT 已依照 […] 進行測試。
皇家飛利浦今日宣布，已簽署協議收購 Respiratory Technologies, Inc.（RespirTech）。該公司總部位於美國，專為慢性阻塞性肺病（COPD）及囊性纖維化等慢性呼吸道疾病患者提供創新的氣道清除解決方案。透過此次收購，飛利浦領先的呼吸照護產品組合將進一步擴展，[…]
多面向的治療方法在提升患者照護品質的同時，亦帶來顯著的財務效益 飛利浦（Royal Philips）公佈了一項最新研究結果(1)，顯示嚴重慢性阻塞性肺病（COPD）(2) 患者的住院費用、支付方成本及住院率均顯著下降。這項名為「透過減少住院次數所節省的成本 […]」的研究
ResMed Inc. 今日宣布，根據迄今為止針對治療後出現中樞性睡眠呼吸中止症（CSA）患者所進行的最大規模分析顯示，患有阻塞性睡眠呼吸中止症且後續發展為中樞性睡眠呼吸中止症（CSA）的患者，在從持續氣道正壓通氣（CPAP）療法轉為適應性伺服通氣（ASV）療法後，治療依從性更高。該研究分析了匿名、[…]
